- Active not recruitingPHASE1
DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy
This study is for adults with a type of lung cancer called small cell lung cancer that has spread. It checks how well a new medicine called BI 764532, given with standard chemotherapy, is tolerated. The main goal is to find the safest dose of BI 764532.
For: Small Cell Lung Carcinoma (SCLC)United States · France · Germany - Active not recruitingPHASE1
DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
This study looks at a new medicine, BI 764532, combined with chemotherapy for advanced neuroendocrine cancers. It aims to find safe doses and see if it helps patients whose cancers have a specific marker called DLL3.
For: Neuroendocrine NeoplasmsUnited States · Belgium · France - Active not recruitingPHASE1
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
This study is for adults with a brain tumour called glioma, where previous treatments haven't worked. It's looking to find the safest highest dose of a new drug, BI 764532, which helps your immune system fight the cancer.
For: GliomaUnited States · Austria · Germany